15 Apr Cell Therapeutics secures $15M from single investor
Struggling Cell Therapeutics has raised enough money to stay afloat. The Seattle-based biotech says it has gained $15 million from a single investor. Though the company refused to disclose the investor;s name, regulatory filings indicate that Cranshire Capital provided the funds. Cranshire also has the right to purchase an additional $5 million in shares within 60 days.
Read full article>>